{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:28:13Z","timestamp":1782289693905,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["PP1900"],"award-info":[{"award-number":["PP1900"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL101972"],"award-info":[{"award-number":["R01HL101972"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1F31HL162467-01A1"],"award-info":[{"award-number":["1F31HL162467-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["U.S. Department of Veterans Affairs"],"award-info":[{"award-number":["U.S. Department of Veterans Affairs"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veterans Health Administration","award":["Veterans Health Administration"],"award-info":[{"award-number":["Veterans Health Administration"]}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","award":["Office of Research and Development"],"award-info":[{"award-number":["Office of Research and Development"]}],"id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["2I01 BX000226"],"award-info":[{"award-number":["2I01 BX000226"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BLR&D Merit Review for Pre-IND studies of Drugs and Biologics","award":["5I01 BX005112"],"award-info":[{"award-number":["5I01 BX005112"]}]},{"name":"Senior Research Career Scientist","award":["1IK6BX004209"],"award-info":[{"award-number":["1IK6BX004209"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["2R42AI122574"],"award-info":[{"award-number":["2R42AI122574"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI148490"],"award-info":[{"award-number":["R21 AI148490"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11011-023-01251-1","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T12:02:26Z","timestamp":1687348946000},"page":"2383-2391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-0016","authenticated-orcid":false,"given":"Tia C. L.","family":"Kohs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5868-7576","authenticated-orcid":false,"given":"Meghan E.","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6712-7028","authenticated-orcid":false,"given":"Ethan C.","family":"Oseas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3162-7100","authenticated-orcid":false,"given":"Laura D.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0532-113X","authenticated-orcid":false,"given":"Erik I.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-8014","authenticated-orcid":false,"given":"David","family":"Gailani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9481-0124","authenticated-orcid":false,"given":"Owen J. T.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1207-6817","authenticated-orcid":false,"given":"Arthur A.","family":"Vandenbark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-6079","authenticated-orcid":false,"given":"Halina","family":"Offner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8170-9331","authenticated-orcid":false,"given":"Norah G.","family":"Verbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"issue":"3","key":"1251_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1084\/jem.20061931","volume":"204","author":"RA Adams","year":"2007","unstructured":"Adams RA, Bauer J, Flick MJ, Sikorski SL et al (2007) The fibrin-derived \u03b3377\u2013395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med 204(3):571\u2013582. https:\/\/doi.org\/10.1084\/jem.20061931","journal-title":"J Exp Med"},{"key":"1251_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.msard.2018.10.008","volume":"27","author":"O Ahmed","year":"2019","unstructured":"Ahmed O, Geraldes R, DeLuca GC, Palace J (2019) Multiple sclerosis and the risk of systemic venous thrombosis: a systematic review. Mult Scler Relat Disord 27:424\u2013430. https:\/\/doi.org\/10.1016\/j.msard.2018.10.008","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"1251_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/(sici)1097-4547(19960915)45:6<680::Aid-jnr4>3.0.Co;2-4","volume":"45","author":"BF Bebo Jr","year":"1996","unstructured":"Bebo BF Jr, Vandenbark AA, Offner H (1996) Male SJL mice do not relapse after induction of EAE with PLP 139\u2013151. J Neurosci Res 45(6):680\u2013689. https:\/\/doi.org\/10.1002\/(sici)1097-4547(19960915)45:6<680::Aid-jnr4>3.0.Co;2-4","journal-title":"J Neurosci Res"},{"key":"1251_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.brainres.2016.12.011","volume":"1657","author":"E Brailoiu","year":"2017","unstructured":"Brailoiu E, Shipsky MM, Yan G, Abood ME, Brailoiu GC (2017) Mechanisms of modulation of brain microvascular endothelial cells function by thrombin. Brain Res 1657:167\u2013175. https:\/\/doi.org\/10.1016\/j.brainres.2016.12.011","journal-title":"Brain Res"},{"key":"1251_CR5","doi-asserted-by":"publisher","unstructured":"Cheng Q, Tucker EI, Pine MS, Sisler I et al (2010) A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood 116(19):3981\u20133989. https:\/\/doi.org\/10.1182\/blood-2010-02-270918","DOI":"10.1182\/blood-2010-02-270918"},{"issue":"1","key":"1251_CR6","doi-asserted-by":"publisher","first-page":"9360","DOI":"10.1038\/s41598-018-27613-9","volume":"8","author":"C-I Choi","year":"2018","unstructured":"Choi C-I, Yoon H, Drucker KL, Langley MR, Kleppe L, Scarisbrick IA (2018) The thrombin receptor restricts Subventricular Zone neural stem cell expansion and differentiation. Sci Rep 8(1):9360\u20139360. https:\/\/doi.org\/10.1038\/s41598-018-27613-9","journal-title":"Sci Rep"},{"issue":"3","key":"1251_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s1474-4422(18)30443-5","volume":"18","author":"GMS Collaborators","year":"2019","unstructured":"Collaborators GMS (2019) Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18(3):269\u2013285. https:\/\/doi.org\/10.1016\/s1474-4422(18)30443-5","journal-title":"Lancet Neurol"},{"key":"1251_CR8","first-page":"187","volume":"24","author":"CB Courville","year":"1959","unstructured":"Courville CB (1959) The effects of heparin in acute exacerbations of multiple sclerosis. Observations and deductions. Bull Los Angel Neuro Soc 24:187\u2013196","journal-title":"Bull Los Angel Neuro Soc"},{"issue":"1","key":"1251_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","volume":"34","author":"D Davalos","year":"2012","unstructured":"Davalos D, Akassoglou K (2012) Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 34(1):43\u201362. https:\/\/doi.org\/10.1007\/s00281-011-0290-8","journal-title":"Semin Immunopathol"},{"issue":"1","key":"1251_CR10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ncomms2230","volume":"3","author":"D Davalos","year":"2012","unstructured":"Davalos D, Kyu Ryu J, Merlini M, Baeten KM et al (2012) Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun 3(1):1227. https:\/\/doi.org\/10.1038\/ncomms2230","journal-title":"Nat Commun"},{"issue":"2","key":"1251_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.24078","volume":"75","author":"D Davalos","year":"2014","unstructured":"Davalos D, Baeten KM, Whitney MA, Mullins ES et al (2014) Early detection of thrombin activity in neuroinflammatory disease. Ann Neurol 75(2):303\u2013308. https:\/\/doi.org\/10.1002\/ana.24078","journal-title":"Ann Neurol"},{"issue":"4","key":"1251_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.bbi.2011.01.009","volume":"25","author":"S Dziennis","year":"2011","unstructured":"Dziennis S, Akiyoshi K, Subramanian S, Offner H, Hurn PD (2011) Role of dihydrotestosterone in post-stroke peripheral immunosuppression after cerebral ischemia. Brain Behav Immun 25(4):685\u2013695. https:\/\/doi.org\/10.1016\/j.bbi.2011.01.009","journal-title":"Brain Behav Immun"},{"key":"1251_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/b978-0-444-52001-2.00011-x","volume":"122","author":"JM Gelfand","year":"2014","unstructured":"Gelfand JM (2014) Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation. Handb Clin Neurol 122:269\u2013290. https:\/\/doi.org\/10.1016\/b978-0-444-52001-2.00011-x","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"1251_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jaut.2010.11.004","volume":"36","author":"K G\u00f6bel","year":"2011","unstructured":"G\u00f6bel K, Pankratz S, Schneider-Hohendorf T, Bittner S et al (2011) Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. J Autoimmun 36(2):106\u2013114. https:\/\/doi.org\/10.1016\/j.jaut.2010.11.004","journal-title":"J Autoimmun"},{"issue":"6","key":"1251_CR15","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ana.24807","volume":"80","author":"K G\u00f6bel","year":"2016","unstructured":"G\u00f6bel K, Kraft P, Pankratz S, Gross CC et al (2016a) Prothrombin and factor X are elevated in multiple sclerosis patients. Ann Neurol 80(6):946\u2013951. https:\/\/doi.org\/10.1002\/ana.24807","journal-title":"Ann Neurol"},{"issue":"1","key":"1251_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11626","volume":"7","author":"K G\u00f6bel","year":"2016","unstructured":"G\u00f6bel K, Pankratz S, Asaridou C-M, Herrmann AM et al (2016b) Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun 7(1):11626. https:\/\/doi.org\/10.1038\/ncomms11626","journal-title":"Nat Commun"},{"issue":"1","key":"1251_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1073\/pnas.1810020116","volume":"116","author":"K G\u00f6bel","year":"2019","unstructured":"G\u00f6bel K, Asaridou C-M, Merker M, Eichler S et al (2019) Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release. Proc Natl Acad Sci 116(1):271\u2013276. https:\/\/doi.org\/10.1073\/pnas.1810020116","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"1251_CR18","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1182\/blood-2003-01-0324","volume":"102","author":"A Gruber","year":"2003","unstructured":"Gruber A, Hanson SR (2003) Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates. Blood 102(3):953\u2013955. https:\/\/doi.org\/10.1182\/blood-2003-01-0324","journal-title":"Blood"},{"issue":"Pt 7","key":"1251_CR19","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/brain\/awg167","volume":"126","author":"D Gveric","year":"2003","unstructured":"Gveric D, Herrera B, Petzold A, Lawrence DA, Cuzner ML (2003) Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors. Brain 126(Pt 7):1590\u20131598. https:\/\/doi.org\/10.1093\/brain\/awg167","journal-title":"Brain"},{"issue":"7182","key":"1251_CR20","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nature06559","volume":"451","author":"MH Han","year":"2008","unstructured":"Han MH, Hwang S-I, Roy DB, Lundgren DH et al (2008) Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451(7182):1076\u20131081. https:\/\/doi.org\/10.1038\/nature06559","journal-title":"Nature"},{"key":"1251_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmedt.2022.901331","volume":"4","author":"AA Hulleck","year":"2022","unstructured":"Hulleck AA, Menoth Mohan D, Abdallah N, El Rich M, Khalaf K (2022) Present and future of gait assessment in clinical practice: towards the application of novel trends and technologies. Front Med Technol 4:901331. https:\/\/doi.org\/10.3389\/fmedt.2022.901331","journal-title":"Front Med Technol"},{"issue":"3","key":"1251_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11011-020-00652-w","volume":"36","author":"KR Jordan","year":"2021","unstructured":"Jordan KR, Parra-Izquierdo I, Gruber A, Shatzel JJ et al (2021) Thrombin generation and activity in multiple sclerosis. Metab Brain Dis 36(3):407\u2013420. https:\/\/doi.org\/10.1007\/s11011-020-00652-w","journal-title":"Metab Brain Dis"},{"issue":"9","key":"1251_CR23","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1111\/jth.15777","volume":"20","author":"KR Jordan","year":"2022","unstructured":"Jordan KR, Wyatt CR, Fallon ME, Woltjer R et al (2022) Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis. J Thromb Haemost 20(9):2035\u20132045. https:\/\/doi.org\/10.1111\/jth.15777","journal-title":"J Thromb Haemost"},{"issue":"9","key":"1251_CR24","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/CIRCRESAHA.111.256370","volume":"110","author":"HF Langer","year":"2012","unstructured":"Langer HF, Choi EY, Zhou H, Schleicher R et al (2012) Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res 110(9):1202\u20131210. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.256370","journal-title":"Circ Res"},{"issue":"3","key":"1251_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12975-012-0186-5","volume":"3","author":"PY Leung","year":"2012","unstructured":"Leung PY, Hurst S, Berny-Lang MA, Verbout NG et al (2012) Inhibition of factor XII-Mediated activation of factor XI provides Protection Against Experimental Acute ischemic stroke in mice. Transl Stroke Res 3(3):381\u2013389. https:\/\/doi.org\/10.1007\/s12975-012-0186-5","journal-title":"Transl Stroke Res"},{"issue":"3","key":"1251_CR26","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1172\/JCI113953","volume":"83","author":"O Lider","year":"1989","unstructured":"Lider O, Baharav E, Mekori YA, Miller T, Naparstek Y, Vlodavsky I, Cohen IR (1989) Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins. J Clin Invest 83(3):752\u2013756. https:\/\/doi.org\/10.1172\/JCI113953","journal-title":"J Clin Invest"},{"issue":"2","key":"1251_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/bloodadvances.2017004879","volume":"2","author":"CU Lorentz","year":"2018","unstructured":"Lorentz CU, Verbout NG, Cao Z, Liu L et al (2018) Factor XI contributes to myocardial ischemia-reperfusion injury in mice. Blood Adv 2(2):85\u201388. https:\/\/doi.org\/10.1182\/bloodadvances.2017004879","journal-title":"Blood Adv"},{"issue":"22","key":"1251_CR28","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood.2021011725","volume":"138","author":"CU Lorentz","year":"2021","unstructured":"Lorentz CU, Tucker EI, Verbout NG, Shatzel JJ et al (2021) The contact activation inhibitor AB023 in heparin free hemodialysis: results of a randomized phase 2 clinical trial. Blood 138(22):2173\u20132184. https:\/\/doi.org\/10.1182\/blood.2021011725","journal-title":"Blood"},{"key":"1251_CR29","first-page":"165","volume":"26","author":"J Maschmeyer","year":"1961","unstructured":"Maschmeyer J, Shearer R, Lonser E, Spindle DK (1961) Heparin potassium in the treatment of chronic multiple sclerosis. Bull Los Angel Neuro Soc 26:165\u2013171","journal-title":"Bull Los Angel Neuro Soc"},{"key":"1251_CR30","doi-asserted-by":"publisher","unstructured":"Merker M, Eichler S, Herrmann AM, Wiendl H, Kleinschnitz C, G\u00f6bel K, Meuth SG (2017) Rivaroxaban ameliorates disease course in an animal model of multiple sclerosis. J Neuroimmunol 313. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.08.013","DOI":"10.1016\/j.jneuroim.2017.08.013"},{"key":"1251_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.msard.2017.09.033","volume":"18","author":"J Miranda Acu\u00f1a","year":"2017","unstructured":"Miranda Acu\u00f1a J, Hidalgo de la Cruz M, Ros AL, Tapia SP, Mart\u00ednez Gin\u00e9s ML, de Andr\u00e9s Frutos CD (2017) Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse. Mult Scler Relat Disord 18:157\u2013160. https:\/\/doi.org\/10.1016\/j.msard.2017.09.033","journal-title":"Mult Scler Relat Disord"},{"key":"1251_CR32","unstructured":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals (2011) Guide for the Care and Use of Laboratory Animals, 8th edn. National Academies Press, Washington, DC"},{"issue":"4","key":"1251_CR33","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/jth.15236","volume":"19","author":"ATP Ngo","year":"2021","unstructured":"Ngo ATP, Jordan KR, Mueller PA, Hagen MW et al (2021) Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice. J Thromb Haemost 19(4):1001\u20131017. https:\/\/doi.org\/10.1111\/jth.15236","journal-title":"J Thromb Haemost"},{"issue":"Suppl","key":"1251_CR34","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1002\/ana.410360718","volume":"36","author":"JH Noseworthy","year":"1994","unstructured":"Noseworthy JH (1994) Clinical scoring methods for multiple sclerosis. Ann Neurol 36(Suppl):S80-85. https:\/\/doi.org\/10.1002\/ana.410360718","journal-title":"Ann Neurol"},{"issue":"4","key":"1251_CR35","doi-asserted-by":"publisher","first-page":"205521731774762","DOI":"10.1177\/2055217317747624","volume":"3","author":"ME Parsons","year":"2017","unstructured":"Parsons ME, O\u2019Connell K, Allen S, Egan K et al (2017) Thrombin generation correlates with disease duration in multiple sclerosis (MS): novel insights into the MS-associated prothrombotic state. Mult Scler J Exp Transl Clin 3(4):2055217317747624. https:\/\/doi.org\/10.1177\/2055217317747624","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"4","key":"1251_CR36","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/jth.12523","volume":"12","author":"PJ Peeters","year":"2014","unstructured":"Peeters PJ, Bazelier MT, Uitdehaag BM, Leufkens HG, De Bruin ML, de Vries F (2014) The risk of venous thromboembolism in patients with multiple sclerosis: the clinical practice research datalink. J Thromb Haemost 12(4):444\u2013451. https:\/\/doi.org\/10.1111\/jth.12523","journal-title":"J Thromb Haemost"},{"key":"1251_CR37","doi-asserted-by":"publisher","unstructured":"Plantone D, Inglese M, Salvetti M, Koudriavtseva T (2019) A perspective of Coagulation Dysfunction in multiple sclerosis and in experimental allergic encephalomyelitis. Front Neurol 9(JAN). https:\/\/doi.org\/10.3389\/fneur.2018.01175","DOI":"10.3389\/fneur.2018.01175"},{"issue":"10","key":"1251_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165172","volume":"11","author":"C Puy","year":"2016","unstructured":"Puy C, Tucker EI, Ivanov IS, Gailani D et al (2016) Platelet-derived short-chain polyphosphates enhance the inactivation of tissue factor pathway inhibitor by activated coagulation factor XI. PLoS ONE 11(10):e0165172. https:\/\/doi.org\/10.1371\/journal.pone.0165172","journal-title":"PLoS ONE"},{"issue":"4","key":"1251_CR39","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1055\/s-0037-1613081","volume":"87","author":"ED Rosen","year":"2002","unstructured":"Rosen ED, Gailani D, Castellino FJ (2002) FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse. Thromb Haemost 87(4):774\u2013776","journal-title":"Thromb Haemost"},{"issue":"1","key":"1251_CR40","doi-asserted-by":"publisher","first-page":"8164","DOI":"10.1038\/ncomms9164","volume":"6","author":"JK Ryu","year":"2015","unstructured":"Ryu JK, Petersen MA, Murray SG, Baeten KM et al (2015) Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation. Nat Commun 6(1):8164\u20138164. https:\/\/doi.org\/10.1038\/ncomms9164","journal-title":"Nat Commun"},{"key":"1251_CR41","doi-asserted-by":"publisher","unstructured":"Ryu JK, Rafalski VA, Meyer-Franke A, Adams RA et al. (2018) Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat Immunol 19(11). https:\/\/doi.org\/10.1038\/s41590-018-0232-x","DOI":"10.1038\/s41590-018-0232-x"},{"issue":"1\u20133","key":"1251_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2007.05.043","volume":"570","author":"WA Schumacher","year":"2007","unstructured":"Schumacher WA, Seiler SE, Steinbacher TE, Stewart AB et al (2007) Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats. Eur J Pharmacol 570(1\u20133):167\u2013174. https:\/\/doi.org\/10.1016\/j.ejphar.2007.05.043","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1251_CR43","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1182\/bloodadvances.2018029983","volume":"3","author":"R Silasi","year":"2019","unstructured":"Silasi R, Keshari RS, Lupu C, Van Rensburg WJ et al (2019) Inhibition of contact-mediated activation of factor XI protects baboons against S aureus-induced organ damage and death. Blood Adv 3(4):658\u2013669. https:\/\/doi.org\/10.1182\/bloodadvances.2018029983","journal-title":"Blood Adv"},{"issue":"2","key":"1251_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11481-009-9175-1","volume":"5","author":"S Sinha","year":"2010","unstructured":"Sinha S, Subramanian S, Emerson-Webber A, Lindner M et al (2010) Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG. J Neuroimmune Pharmacol 5(2):231\u2013239. https:\/\/doi.org\/10.1007\/s11481-009-9175-1","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"1251_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12974-017-0926-2","volume":"14","author":"L Stolz","year":"2017","unstructured":"Stolz L, Derouiche A, Devraj K, Weber F, Brunkhorst R, Foerch C (2017) Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis. J Neuroinflammation 14(1):152. https:\/\/doi.org\/10.1186\/s12974-017-0926-2","journal-title":"J Neuroinflammation"},{"issue":"4","key":"1251_CR46","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1182\/blood-2008-06-163675","volume":"113","author":"EI Tucker","year":"2009","unstructured":"Tucker EI, Marzec UM, White TC, Hurst S et al (2009) Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood 113(4):936\u2013944. https:\/\/doi.org\/10.1182\/blood-2008-06-163675","journal-title":"Blood"},{"issue":"20","key":"1251_CR47","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1182\/blood-2011-10-386185","volume":"119","author":"EI Tucker","year":"2012","unstructured":"Tucker EI, Verbout NG, Leung PY, Hurst S, McCarty OJ, Gailani D, Gruber A (2012) Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis. Blood 119(20):4762\u20134768. https:\/\/doi.org\/10.1182\/blood-2011-10-386185","journal-title":"Blood"},{"issue":"1","key":"1251_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11011-014-9558-8","volume":"30","author":"NG Verbout","year":"2015","unstructured":"Verbout NG, Yu X, Healy LD, Phillips KG et al (2015) Thrombin mutant W215A\/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis. Metab Brain Dis 30(1):57\u201365. https:\/\/doi.org\/10.1007\/s11011-014-9558-8","journal-title":"Metab Brain Dis"},{"issue":"6","key":"1251_CR49","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1111\/j.1471-4159.2006.04081.x","volume":"98","author":"C Wang","year":"2006","unstructured":"Wang C, Gold BG, Kaler LJ, Yu X et al (2006) Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE. J Neurochem 98(6):1817\u20131827. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04081.x","journal-title":"J Neurochem"},{"key":"1251_CR50","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2019.00286","volume":"10","author":"J Wang","year":"2019","unstructured":"Wang J, Wang J, Wang J, Yang B, Weng Q, He Q (2019) Targeting microglia and macrophages: a potential treatment strategy for multiple sclerosis. Front Pharmacol 10:286. https:\/\/doi.org\/10.3389\/fphar.2019.00286","journal-title":"Front Pharmacol"},{"issue":"5","key":"1251_CR51","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/glia.22788","volume":"63","author":"H Yoon","year":"2015","unstructured":"Yoon H, Radulovic M, Drucker KL, Wu J, Scarisbrick IA (2015) The thrombin receptor is a critical extracellular switch controlling myelination. Glia 63(5):846\u2013859. https:\/\/doi.org\/10.1002\/glia.22788","journal-title":"Glia"},{"key":"1251_CR52","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neuroscience.2019.05.040","volume":"413","author":"D Zamolodchikov","year":"2019","unstructured":"Zamolodchikov D, Bai Y, Tang Y, McWhirter JR, Macdonald LE, Alessandri-Haber N (2019) A short isoform of coagulation factor XII mRNA is expressed by neurons in the human brain. Neurosci 413:294\u2013307. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.05.040","journal-title":"Neurosci"},{"issue":"22","key":"1251_CR53","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1182\/blood-2010-04-277798","volume":"116","author":"H Zhang","year":"2010","unstructured":"Zhang H, Lowenberg EC, Crosby JR, MacLeod AR et al (2010) Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Blood 116(22):4684\u20134692. https:\/\/doi.org\/10.1182\/blood-2010-04-277798","journal-title":"Blood"},{"key":"1251_CR54","doi-asserted-by":"publisher","unstructured":"Ziliotto N, Baroni M, Straudi S, Manfredini F et al. (2018) Coagulation factor XII levels and intrinsic thrombin generation in multiple sclerosis. Front Neurol 9(APR). https:\/\/doi.org\/10.3389\/fneur.2018.00245","DOI":"10.3389\/fneur.2018.00245"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-023-01251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-023-01251-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-023-01251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T06:10:40Z","timestamp":1694758240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-023-01251-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1007\/s11011-023-01251-1","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal care and procedures in this study were performed in accordance with the National Institutes of Health <i>Guide for the Care and Use of Laboratory Animals<\/i> and the regulations of the Oregon Health & Science University Institutional Animal Care and Use Committee (National Research Council Committee for the Update of the Guide for the C and Use of Laboratory A ). The male C57BL\/6 mice used in this study were housed at the Portland Veterans Affairs Medical Center in the Animal Resource Facility (Portland, OR, US) according to guidelines set by the National Research Council and the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"E.I. Tucker and N.G. Verbout are employees of Aronora, Inc., a company that may have financial interest in the study results. The Oregon Health & Science University Conflict of Interest in Research Committee has reviewed and managed this potential conflict of interest. The remaining authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}